Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Allogeneic Hematopoietic Cell Transplantation for Patients With High Grade Central Nervous System Malignancies

NCT04521946 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04521946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04521946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Allogeneic Hematopoietic Cell Transplantation for Patients With High Grade Central Nervous System Malignancies
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Withdrawn
Start date
January 14, 2021
Completion date
December 20, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic ependymoma, atypical teratoid/rhabdoid tumor, central nervous system germ cell tumor, choroid plexus carcinoma, intracranial myeloid sarcoma, malignant brain neoplasm, malignant glioma, medulloblastoma, primitive neuroectodermal tumor, recurrent anaplastic ependymoma, recurrent atypical teratoid/rhabdoid tumor, recurrent malignant brain neoplasm, recurrent malignant glioma, recurrent medulloblastoma, recurrent primitive neuroectodermal tumor